ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
1,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1,5,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
3,1,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,Y
4,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
5,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
7,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
9,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
9,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
9,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
9,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
9,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
9,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
10,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
11,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
11,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
12,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
12,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
13,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
13,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
14,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
15,1,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,Y
16,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
16,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
17,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
17,2,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,Y
18,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
18,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
18,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
19,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
19,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
20,1,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
21,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
22,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
22,2,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
22,3,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
22,4,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
22,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
23,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
23,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
23,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
23,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
24,1,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
25,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
25,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
25,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
26,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
27,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
28,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
29,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
30,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
31,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
32,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
33,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
33,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
34,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
35,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
36,1,Cellulitis orbital,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
36,2,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
37,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
38,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
38,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
39,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
39,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
39,3,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
39,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
39,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
40,1,Glucose urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
41,1,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
42,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
42,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
42,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
43,1,Cauda equina syndrome,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
43,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
43,3,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,Y
44,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
45,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
46,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
47,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
49,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
50,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
50,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
51,1,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
52,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
52,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
53,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
54,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
55,1,Bone marrow oedema,Haematological disorders,Haematological disorders NEC,Blood,N
55,2,Pathological fracture,Fractures NEC,Fractures,Musc,N
56,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
57,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
58,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
58,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
58,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
59,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
60,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
61,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
61,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
62,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
62,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
62,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
63,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
64,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
64,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
64,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
65,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
65,2,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
65,3,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
65,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,Y
65,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
66,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
67,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
67,2,Large intestinal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
68,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
69,1,Calcification of muscle,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
69,2,Pathological fracture,Fractures NEC,Fractures,Musc,N
70,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
70,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
71,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
72,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
72,2,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
72,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
73,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
73,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
73,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
74,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
74,2,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
75,1,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
76,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
77,1,Blood calcium abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
77,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
77,3,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
78,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
78,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
79,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
79,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
80,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
80,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
81,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
82,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
82,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
82,3,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
83,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
83,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
84,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
84,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
85,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
85,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
85,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
86,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
86,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
86,3,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
86,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
87,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
87,2,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
87,3,Electrocardiogram T wave inversion,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
87,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
88,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
88,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
88,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
89,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
90,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
90,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
90,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
91,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
92,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
92,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
93,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
94,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
94,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
94,3,Palatal disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
94,4,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
95,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
96,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
97,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
98,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
98,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
98,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
98,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
98,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
99,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
100,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
101,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
101,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
102,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
103,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
103,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,Y
103,3,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
104,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
104,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
104,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
105,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
106,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
106,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
106,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
107,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
108,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
108,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
109,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
109,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
109,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
109,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
109,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
110,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
110,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
110,3,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
111,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
112,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
113,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
113,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
114,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
115,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
116,1,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
117,1,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
118,1,Acquired dysfibrinogenaemia,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
118,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
118,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
118,4,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
118,5,Spinal cord haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
119,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
120,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
120,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
120,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
121,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
121,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
122,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
122,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
122,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
123,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
124,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
124,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
124,3,Duodenal polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
124,4,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
124,5,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
124,6,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
124,7,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
124,8,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
124,9,Salmonellosis,Salmonella infections,Bacterial infectious disorders,Infec,N
124,10,Spinal osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
125,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
126,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
126,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
127,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
127,2,Volvulus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
128,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
128,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
129,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
129,2,Abdominal rigidity,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
129,3,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
129,4,Intestinal infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
129,5,Volvulus of small bowel,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
130,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
130,2,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
130,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
130,4,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
130,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
130,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
130,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
130,8,Genital pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
130,9,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
130,10,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
130,11,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
130,12,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
131,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
131,2,Eye injury,Eye injuries NEC,Injuries NEC,Inj&P,N
131,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
131,4,Open globe injury,Eye injuries NEC,Injuries NEC,Inj&P,N
132,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
133,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
133,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
133,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
133,4,Claustrophobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
133,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
133,6,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
133,7,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
133,8,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
133,9,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
133,10,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,Y
134,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
135,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
135,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
136,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
137,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
138,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
138,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
139,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
139,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
139,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
140,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
140,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
141,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
141,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
141,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
142,1,Blood albumin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
142,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
142,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
142,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
142,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
143,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
143,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
143,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
143,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
144,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
144,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
144,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
145,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
145,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
145,3,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
146,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
146,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
146,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
146,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
147,1,Blood albumin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
147,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
147,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
147,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
147,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
148,1,Blood albumin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
148,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
148,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
148,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
148,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
149,1,Blood albumin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
149,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
149,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
150,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
150,2,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
151,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
151,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
151,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
152,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
152,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
152,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
153,1,Blood albumin abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
153,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
153,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
153,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
154,1,Blood albumin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
154,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
154,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
154,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
154,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
155,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
155,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
155,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
155,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
156,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
156,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
156,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
156,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
157,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
157,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
157,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
158,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
159,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
159,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
159,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
159,4,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
160,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
161,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
161,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
161,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
162,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
163,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
163,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
163,3,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
163,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
163,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
164,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
164,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
164,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
164,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
165,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
165,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
165,3,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
165,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
166,1,Retinal vein thrombosis,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
167,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
167,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
168,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
169,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
169,2,Cardiac function test abnormal,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
169,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
169,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
170,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
170,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
171,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
172,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
173,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
173,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
173,3,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
173,4,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
174,1,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
174,2,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
175,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
175,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
176,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
177,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
177,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
178,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
178,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
179,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
180,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
181,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
181,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
182,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
182,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
182,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
182,4,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,Y
183,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
184,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
185,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
185,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
186,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
186,2,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
187,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
187,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
187,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
188,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
189,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
189,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
189,3,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
190,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
190,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
191,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
191,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
192,1,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
192,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
192,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
192,4,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
192,5,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
193,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
193,2,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
194,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
194,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
194,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
195,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
195,2,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
195,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
196,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
196,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
197,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
197,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
197,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
197,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
198,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
199,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
200,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
200,2,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
201,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
201,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
202,1,Abdominal lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
202,2,Atelectasis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
202,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
202,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
202,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
203,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
204,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
205,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
205,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
206,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
207,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
207,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
207,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
207,4,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
207,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
208,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
209,1,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
210,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
211,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
211,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
211,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
211,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
212,1,Acute biphenotypic leukaemia,Leukaemias acute NEC,Leukaemias,Neopl,N
213,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
213,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
214,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
215,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
216,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
216,2,Blood bicarbonate increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
217,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
218,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
218,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
219,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
220,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
221,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
222,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
222,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
223,1,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
223,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
223,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
223,4,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
224,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
225,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
225,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
226,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
227,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
227,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
227,3,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
228,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
228,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
228,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
229,1,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
230,1,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
231,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
231,2,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
232,1,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
233,1,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
234,1,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
235,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
235,2,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
236,1,Metastatic carcinoma of the bladder,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
237,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
237,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
237,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
237,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
237,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
238,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
238,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
239,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
239,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
239,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
240,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
240,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
241,1,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
242,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
242,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
242,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
242,4,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
243,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
243,2,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
244,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
244,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
245,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
245,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
246,1,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
247,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
248,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
249,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
249,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
249,3,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
250,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
251,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
252,1,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
252,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
252,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
253,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
253,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
254,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
255,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
256,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
257,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
258,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
259,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
259,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
260,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
260,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
260,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
260,4,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
261,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
262,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
263,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
264,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
265,1,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
266,1,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
267,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
268,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
269,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
269,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
269,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
269,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
269,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
269,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
269,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
270,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
270,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
270,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
270,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
270,5,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
271,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
271,2,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
271,3,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
271,4,Tension headache,Headaches NEC,Headaches,Nerv,N
272,1,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
273,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
273,2,Haemorrhage subcutaneous,Skin haemorrhages,Skin vascular abnormalities,Skin,N
273,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
274,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
274,2,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
275,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
276,1,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
277,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
278,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
278,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
279,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
280,1,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
281,1,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
282,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
282,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
282,3,Infective exacerbation of chronic obstructive airways disease,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
283,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
284,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
285,1,Myopathy,Myopathies,Muscle disorders,Musc,N
286,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
286,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
286,3,Infective exacerbation of chronic obstructive airways disease,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
287,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
288,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
289,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
289,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
289,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
290,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
290,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
290,3,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
290,4,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
291,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
291,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
292,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
292,2,Pharyngeal abscess,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
293,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
294,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
294,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
294,3,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
294,4,Electrocardiogram ST segment depression,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
295,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
295,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
296,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
297,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
297,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
297,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
297,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
298,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
299,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
299,2,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
300,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
301,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
302,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
302,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
303,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
303,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
303,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
304,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
305,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
306,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
306,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
306,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
307,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
308,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
308,2,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
309,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
309,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
309,3,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
310,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
310,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
311,1,Metastatic lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
311,2,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
312,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
312,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
312,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
313,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
313,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
313,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
314,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
314,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
314,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
315,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
315,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
315,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
316,1,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
317,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
318,1,Orbital haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
319,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
320,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
320,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
320,3,Product size issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
321,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
321,2,Product size issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
322,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
323,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
323,2,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
323,3,Haematinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
323,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
323,5,Malignant urinary tract neoplasm,Urinary tract neoplasms malignant NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
324,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
325,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
325,2,Cardiac failure acute,Heart failures NEC,Heart failures,Card,N
325,3,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
325,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
325,5,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
325,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
326,1,Nephrostomy,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
327,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
328,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
329,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
330,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
331,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
331,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
331,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
332,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
333,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
333,2,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
334,1,Hip surgery,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
335,1,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
336,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
337,1,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
338,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
338,2,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
339,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
340,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
341,1,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
342,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
342,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
342,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
343,1,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
344,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
345,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
345,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
345,3,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
346,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
346,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
347,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
347,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
347,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
347,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
347,5,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
348,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
348,2,Prostatic specific antigen abnormal,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
349,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
350,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
351,1,Neck mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
352,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
353,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
353,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
353,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
353,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
354,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
354,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
355,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
355,2,Headache,Headaches NEC,Headaches,Nerv,N
356,1,Headache,Headaches NEC,Headaches,Nerv,N
357,1,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
358,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
358,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
358,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
358,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
359,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
359,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
360,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
361,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
362,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
363,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
364,1,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
365,1,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
366,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
367,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
367,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
367,3,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
368,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
368,2,Headache,Headaches NEC,Headaches,Nerv,N
369,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
369,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
369,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
369,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
369,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
370,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
370,2,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
370,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
370,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
371,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
372,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
372,2,Headache,Headaches NEC,Headaches,Nerv,N
373,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
374,1,Prostatectomy,Prostatic therapeutic procedures,Male genital tract therapeutic procedures,Surg,N
374,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
375,1,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
375,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
376,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
377,1,Bladder spasm,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
377,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
377,3,Product size issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
378,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
378,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
378,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
378,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
379,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
379,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
380,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
381,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
382,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
382,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
382,3,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
382,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
382,5,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
382,6,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
382,7,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
383,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
384,1,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
385,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
385,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
386,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
387,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
388,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
388,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
388,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
388,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
388,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
388,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
389,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
390,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
391,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
391,2,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
391,3,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
391,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
391,5,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
391,6,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
391,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
392,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
392,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
392,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
392,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
393,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
393,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
394,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
394,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
394,3,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
394,4,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
395,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
396,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
396,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
397,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
397,2,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
398,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
398,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
399,1,Oral administration complication,Administration site reactions NEC,Administration site reactions,Genrl,N
399,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
399,3,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
399,4,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
400,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
401,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
401,2,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
401,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
401,4,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
402,1,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
403,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
404,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
405,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
405,2,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
406,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
406,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
406,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
406,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
406,5,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
406,6,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
406,7,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
406,8,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
406,9,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
406,10,Metastases to spine,Metastases to specified sites,Metastases,Neopl,N
406,11,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
406,12,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
406,13,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
406,14,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
406,15,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
406,16,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
406,17,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
406,18,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
406,19,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
407,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
408,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
409,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
410,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
410,2,Product size issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
410,3,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
410,4,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
410,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
411,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
412,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
413,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
413,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
414,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
414,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
414,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
415,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
416,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
417,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
418,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
419,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
420,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
420,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
421,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
421,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
421,3,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
421,4,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
422,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
422,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
422,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
422,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
423,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
424,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
425,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
425,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
426,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
427,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
427,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
427,3,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
427,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
427,5,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
428,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
428,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
428,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
429,1,Hormone-refractory prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
430,1,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
431,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
431,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
431,3,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
432,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
433,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
434,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
435,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
436,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
436,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
436,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
436,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
436,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
437,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
437,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
437,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
438,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
439,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
440,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
440,2,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
440,3,Metastases to spine,Metastases to specified sites,Metastases,Neopl,N
440,4,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
441,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
441,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
441,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
442,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
442,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
443,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
444,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
445,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
446,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
447,1,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
448,1,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
449,1,Device occlusion,Device malfunction events NEC,Device issues,Prod,N
450,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
450,2,Tumour marker abnormal,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
451,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
451,2,Product size issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
452,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
452,2,Haematological infection,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
452,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
452,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
453,1,Gastric operation,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
454,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
455,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
456,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
457,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
457,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
458,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
459,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
460,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
460,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
460,3,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
460,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
460,5,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
461,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
462,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
462,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
462,3,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
463,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
464,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
464,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
465,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
465,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
466,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
467,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
467,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
468,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
468,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
469,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
470,1,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
471,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
472,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
472,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
473,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
474,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
475,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
476,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
476,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
477,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
477,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
478,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
478,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
478,3,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
478,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
478,5,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
478,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
479,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
480,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
480,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
481,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
481,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
482,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
483,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
483,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
483,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
484,1,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
485,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
486,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
487,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
488,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
489,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
489,2,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
489,3,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
489,4,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
489,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
489,6,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
489,7,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
489,8,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
490,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
491,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
491,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
492,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
493,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
493,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
493,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
494,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
495,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
496,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
497,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
498,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
499,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
500,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
501,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
502,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
503,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
504,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
504,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
504,3,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
505,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
506,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
507,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
508,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
508,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
508,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
508,4,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
508,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
509,1,Oral mucosal exfoliation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
510,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
511,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
512,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
513,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
514,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
515,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
516,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
516,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
517,1,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
517,2,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
518,1,Headache,Headaches NEC,Headaches,Nerv,N
519,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
520,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
520,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
521,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
521,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
522,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
523,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
524,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
524,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
524,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
525,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
525,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
526,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
527,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
528,1,Haemochromatosis,Iron excess,Iron and trace metal metabolism disorders,Metab,N
529,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
530,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
531,1,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
531,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
